Tattoo Ink Chemistry, Particle Physics & Safety
Tattoo ink chemistry determines both the safety and the permanence of dermal pigmentation. This reference covers pigment particle physics, organic versus inorganic pigment tradeoffs, carrier fluid science, EU Regulation (EU) 2020/2081 banned substances, heavy metal concentration limits, lightfastness standards, and a systematic protocol for evaluating ink safety before purchase or use.
⚡ Quick Reference
Critical Numbers
- Optimal particle size for dermal retention50–300 nm diameter (sub-micron, above phagocyte capture threshold)
- EU (2020/2081) bannedBlue 15:3 (PB15:3) and Green 7 (PG7) now restricted — transition deadline Jan 2023
- Nickel limit< 0.001% by weight (EU Regulation 2020/2081 Annex XVII, Entry 27)
- Aromatic amine (from azo dyes)must not exceed 0.001% in final ink product under EU rules
- Polycyclic aromatic hydrocarbons (PAH)benzo[a]pyrene < 0.00005%; sum of 8 PAHs < 0.0005%
- Lightfastness minimum standardASTM D4303 Blue Wool Scale ≥ 7 (standard), ≥ 8 (preferred for vibrant colours)
- Carrier fluid pH6.5–8.0 — outside this range increases dermal irritation risk
- Sterility requirementsterile for implantable use — ISO 11135 (EO) or equivalent, SAL 10⁻⁶
Key chemical and physical parameters for professional tattoo ink evaluation and compliance.
Tattoo ink is a two-component system: a pigment phase (solid colour particles, 50–300 nm diameter) suspended in a carrier phase (aqueous or alcohol-based liquid delivery medium). Once injected into the mid-dermis by repeated needle penetration, the pigment particles are engulfed by resident macrophages and fibroblasts. Because the particles are too large for the cells to fully digest, they remain trapped within the cell cytoplasm indefinitely — which is precisely the mechanism of long-term colour retention. The permanence of a tattoo is literally the permanence of cellular entrapment, not chemical bonding.
The carrier fluid is not merely a diluent — it determines whether pigment particles reach the dermis in a dispersed, evenly distributed suspension or as agglomerated clumps. Agglomerated pigment produces uneven colour saturation, hot spots of particle density, and unpredictable laser removal outcomes. A professionally formulated carrier maintains consistent particle dispersion, provides lubrication during needle penetration, inhibits microbial growth between uses, and delivers the correct viscosity (500–2,000 cP) for capillary wicking through needle groupings. Studios that dilute inks with tap water are unknowingly collapsing dispersion chemistry, risking contamination, and altering viscosity — all at once.
Particle Size Physics: The Phagocytosis Balance
Particle diameter is the central physical variable that determines whether pigment is retained in the dermis or cleared by the immune system — and it operates within a narrow functional window.
- »Sub-50 nm particles (nanoparticles): Below the lower threshold of reliable macrophage capture. These particles can transit into the lymphatic system and have been detected in lymph nodes in autopsy studies. Regulatory concern is increasing — EU has specifically flagged nano-pigment toxicology as an open question.
- »50–300 nm (optimal range): Large enough for reliable macrophage engulfment and retention in the dermis, small enough to maintain stable colloidal suspension in carrier fluid. This is the design target for professionally formulated inks.
- »300 nm–1 μm: Particles in this range are retained but may produce visibly granular colour in fine detail work (visible as speckling under magnification). They also resist laser fragmentation more than smaller particles, requiring more treatment sessions for removal.
- »> 1 μm particles: Agglomerates or poorly milled pigments. These cannot be uniformly suspended — they settle rapidly in the bottle and, when injected, create uneven density in the dermis. They are also the primary cause of "muddy" or over-saturated colour patches.
- »Phagocyte dynamics over time: Macrophage cell death over years releases pigment particles, which are then re-engulfed by new macrophages or daughter cells. This cycle continues indefinitely, which is why tattoos fade very slowly — not because pigment dissolves, but because each re-engulfment cycle relocates a small fraction of particles slightly outward toward the epidermis.
Organic vs. Inorganic Pigments: The Real Tradeoffs
The distinction between organic and inorganic pigments is not a simple safe/unsafe binary — it is a tradeoff matrix across colour gamut, long-term stability, toxicological profile, and laser removal behaviour.
- »Inorganic pigments (iron oxides, titanium dioxide, carbon black): Iron oxides produce the brown, red, yellow, and ochre palette. Carbon black produces black. Titanium dioxide produces white and pastels when mixed. Generally considered among the safest pigment families — well-characterised toxicology, no carcinogenic azo degradation products. Limitation: limited colour gamut (no pure blue, green, or violet from inorganic sources).
- »Organic pigments — azo family: Most red, orange, and yellow pigments are azo compounds. The regulatory concern is reductive cleavage: under UV exposure, laser irradiation, or metabolic processes, some azo pigments can cleave into aromatic amines, several of which are classified as carcinogens (e.g., benzidine, 4-aminobiphenyl). EU Regulation 2020/2081 bans the use of azo pigments that can release these specific amines above 0.001% in the ink formulation.
- »Organic pigments — phthalocyanine family: Blue 15:3 (copper phthalocyanine) and Green 7 were the dominant blue and green pigments in tattoo ink for decades. EU banned them under Regulation 2020/2081 due to lung toxicology concerns from occupational inhalation data (industrial context). The dermal toxicology evidence is less clear — but the ban applies regardless. Alternatives (PB15:1, PB29) are now in use but produce slightly different colour fidelity.
- »Polycyclic aromatic hydrocarbons (PAHs): A contamination concern primarily in carbon black pigments. Certain PAHs (benzo[a]pyrene, benz[a]anthracene) are classified as carcinogens at sufficient dose. EU sets strict concentration limits; reputable manufacturers test each batch.
- »Heavy metals: Cadmium (historic red/yellow pigments), chromium, nickel, lead, and mercury have been used historically. EU Annex XVII Entry 27 now sets strict weight limits for 11 heavy metals in tattoo inks. Cadmium and mercury are effectively prohibited.
Carrier Fluid Science
The carrier is the liquid phase that holds pigment particles in suspension and delivers them to the dermis. Its formulation directly affects pigment dispersion stability, needle wicking behaviour, in-situ sterility, and post-injection tissue response.
- »Aqueous base (distilled or purified water): Provides the primary suspension medium. Must be sterile and free of endotoxins (pyrogen-free). Tap water is categorically unsuitable — mineral content disrupts dispersion chemistry and introduces bacterial contamination.
- »Glycerin (glycerol): Humectant and viscosity modifier. Increases ink viscosity and helps pigment particles remain in suspension longer between uses. Standard concentration 1–10%. At > 20%, glycerin can impede needlewicking through tight groupings.
- »Isopropyl alcohol (IPA) / Ethanol: Antimicrobial preservative and surface tension modifier. Typical concentration 1–5%. IPA also acts as a wetting agent, improving pigment particle dispersion. High concentrations increase tissue irritation and accelerate carrier evaporation during a session (thickening the ink pool in the cap).
- »Propylene glycol (PG): Common carrier addition for viscosity adjustment and antimicrobial function. Generally recognised as safe at cosmetic concentrations; rare skin sensitiser in susceptible individuals. Some premium inks avoid PG entirely and use glycerin as the primary viscosity agent.
- »Dispersants and surfactants: Prevent pigment agglomeration during storage. Polysorbate 20 and 80 are common choices. Absence of a dispersant is why cheap inks separate dramatically in the bottle and require vigorous shaking to re-homogenise.
- »pH: The carrier should be formulated to pH 6.5–8.0. Acidic carriers (< 6.0) cause burning sensation and increased dermal irritation. Alkaline carriers (> 8.5) can cause protein denaturation at the injection site. Most professional inks are buffered to ~7.0.
Ink Safety Evaluation Protocol
Systematic steps for evaluating tattoo ink safety before purchase and at point of use — applying EU 2020/2081 and professional quality standards.
- 1Step 1 — Verify EU Regulation 2020/2081 compliance: obtain the manufacturer's Certificate of Conformity (CoC) and/or Certificate of Analysis (CoA) for the specific batch. These documents must confirm absence of banned substances and metals below prescribed limits. Certificates must reference the specific regulation, not generic "compliance" claims.
- 2Step 2 — Check pigment CAS numbers against EU restricted list: every ink product should disclose its pigment CAS numbers (e.g., Blue 15:3 = CAS 147-14-8 — now banned). If the manufacturer does not disclose CAS numbers, do not purchase.
- 3Step 3 — Inspect particle size disclosure: professional manufacturers publish median particle size (D50) data, typically from laser diffraction analysis. Target D50: 100–250 nm. Absence of particle size data indicates inadequate quality control.
- 4Step 4 — Verify sterility certification: the ink must be labelled "sterile" with a lot number and expiry date traceable to a validated sterilization run. Inks labelled only "preservative-added" or "antimicrobial" are NOT sterile in the ISO sense.
- 5Step 5 — Check pH: use a calibrated pH strip or metre on a fresh drop of ink before use. Target: 6.5–8.0. Reject any ink outside this range until manufacturer provides explanation.
- 6Step 6 — Inspect bottle and labelling: the lot number, pigment disclosure, ingredient list, sterilization method, expiry date, and manufacturer contact details must all be present. EU labelled inks must carry CE marking under MDR 2017/745 framework. Missing information = presumed non-compliant.
- 7Step 7 — Pre-session inspection: check for sedimentation (normal for some pigments — resuspend by inversion), unusual colour shift (may indicate pigment degradation or contamination), or viscosity change from previous sessions (thickening suggests carrier evaporation or bacterial growth).
- 8Step 8 — Patch test for known sensitisers: for clients with reported nickel allergy or known skin sensitivities, a 48-hour patch test with the specific ink planned for use is advisable — particularly for red and yellow azo pigments, which account for the majority of tattoo allergic reactions.
- 9Step 9 — Single-session dispensing: dispense ink into single-use pigment caps. Never return unused ink from a cap to the master bottle — contamination risk. Discard all cap contents at end of each session.
- 10Step 10 — Dilution rules: if dilution is required (for washes or grey shading), use only sterile distilled water or a commercial sterile ink diluent. Never use tap water, bottled drinking water, or saline not formulated for this purpose.
Critical Errors
Common ink chemistry and handling errors with documented consequences.
- ✕Using inks that contain banned EU 2020/2081 pigments on EU-resident clients: regulatory violation in all EU member states since January 2023. Studios sourcing non-compliant inks from non-EU suppliers remain liable under EU law if they apply them within the EU.
- ✕Treating "vegetable-based" or "organic" marketing claims as safety guarantees: azo dyes are organic compounds. "Plant-based" carrier ingredients do not prevent pigment from containing banned aromatic amines. Regulatory compliance requires third-party batch testing, not marketing language.
- ✕Diluting ink with tap water: introduces chlorine (disrupts pH and dispersant chemistry), calcium and magnesium salts (precipitate with dispersants, causing agglomeration), and bacterial contamination. The resulting mixture may look unchanged but has compromised both chemistry and sterility.
- ✕Ignoring sedimentation as normal: while some sedimentation is expected, heavy settling that reforms within minutes after shaking indicates inadequate dispersant or particle sizes too large to remain in colloidal suspension. This ink will produce uneven dermis deposition regardless of technique.
- ✕Storing opened ink at room temperature between sessions: accelerates microbial growth in non-sterile environments. Single-use dispensing into caps eliminates this risk; the master bottle should be stored per manufacturer instructions (typically refrigerated after opening).
- ✕Not verifying CoA/batch documentation: inks sold without batch-level chemical testing are unverifiable. "Our inks meet EU standards" without a specific batch CoA means nothing. Sourcing unverified inks creates practitioner liability for client adverse events.
- ✕Overlooking small tattoo surface area as "low dose": even small tattoos implant ~2.5 mg of dry pigment per cm². For a full-sleeve tattoo, total pigment load can exceed 1 g. Systemic exposure from dermal pigment is not zero — this is specifically why heavy metal limits are set at weight fraction rather than total dose thresholds.
Tattoo Ink Regulatory Standards
Key regulations and standards governing tattoo ink chemical safety and manufacture across major jurisdictions.
- EU Regulation (EU) 2020/2081: Restricts use of ~4,000 substances in tattoo inks and permanent make-up. Includes ban on Blue 15:3 and Green 7, limits on azo dyes, PAHs, and 11 heavy metals
- REACH Regulation (EC) No 1907/2006: Restricts substances of very high concern (SVHC) — applies to inks as chemical mixtures
- ResAP(2008)1: Council of Europe Resolution on tattooing and permanent make-up (now largely superseded by 2020/2081 but still referenced in some member states)
- EU Medical Devices Regulation 2017/745: Provides MDR classification framework; CE marking requirements apply to some ink products depending on claim scope
- ISO/TR 17276:2015: Technical report providing analytical methods for tattoo ink characterisation — the reference framework for batch testing
- FDA 21 CFR Part 700: Cosmetics regulations — tattoo inks are regulated as cosmetics (applied to body surface), but rules are substantially weaker than EU 2020/2081
- FDA has no pre-market approval requirement for tattoo inks as of 2026 — relies on post-market surveillance and adverse event reporting
- FDA MedWatch: Adverse event reporting system — studios have voluntary reporting obligation for serious reactions
- California Prop 65: Some states impose additional heavy metal and carcinogen disclosure requirements; California requires Prop 65 warning labels for inks containing listed chemicals above thresholds
- ASTM D4303: Standard method for lightfastness of colorants — widely referenced for pigment stability testing even though not a tattoo-specific standard
- Thailand: No specific tattoo ink regulation as of 2026; inks fall under cosmetics law (Cosmetics Act B.E. 2558); heavy metal limits follow ASEAN Cosmetic Directive
- ASEAN Cosmetic Directive (2003): Common framework adopted by all 10 ASEAN states; restricts heavy metals and prohibited colorants in cosmetics — applied by extension to tattoo inks in some member states
- Australia (comparator): TGA has issued specific guidance on tattooing — inks regulated under Therapeutic Goods Act; nickel and heavy metal limits align broadly with EU; practitioners required to use TGA-listed products for therapeutic claims
- Singapore: HSA Cosmetic Products regulations apply; Annex II prohibited substances list and Annex IV restricted colorants list enforced
- Industry best practice (all ASEAN): EU 2020/2081 CoA certificates are accepted as de facto safety proof in the absence of equivalent domestic standards — sourcing EU-compliant inks protects studios in all jurisdictions
Patrick's Note
"I spent years watching studios choose inks based on colour vibrancy in the bottle and the price per millilitre. The chemistry conversation was practically non-existent. Then the EU regulation came in — EU 2020/2081 — and suddenly the industry had to scramble. Blue 15:3 was in virtually every blue ink on the market. Green 7 was in virtually every forest green. The manufacturers knew. They had the toxicology data. They just never had to act on it until a regulator forced the issue. I find this familiar. The same dynamic played out with body jewelry materials — regulators applying blanket rules without distinguishing between actually dangerous materials and certified, tested alternatives. The difference with ink regulation is that the EU actually got the chemistry right in most areas. The PAH and azo amine limits are scientifically grounded. The nano-pigment concern is a legitimate open question. If you are still using inks without batch-level CoAs in 2026, you are not just taking a regulatory risk — you are making a clinical decision about what to inject into your clients' dermis without adequate information to make that decision responsibly. That is not a standard a professional should accept for themselves."
Founder & Piercing Expert
Poli International
Related Topics
- »Metallic Biocompatibility: /wiki/metallic-biocompatibility/
- »Wound Healing Biology: /wiki/wound-healing-biology/
- »Laser Interaction Physics: /wiki/laser-interaction-physics/
- »Journal: Pigment Science (Tech Watch): /blog/?category=Tech%20Watch
Technical Specifications
| Parameter | Standard / Value |
|---|---|
| Optimal Particle Size (D50) | 100–250 nm |
| Phagocytosis Escape Threshold | > 50 nm diameter |
| Lymphatic Clearance Risk | < 50 nm (nano range) |
| Carrier pH Target | 6.5–8.0 |
| Viscosity Range (optimal wicking) | 500–2,000 cP |
| Lightfastness Standard | ASTM D4303 Blue Wool ≥ 7 |
| Sterility Assurance Level | SAL 10⁻⁶ (ISO 11135 or equivalent) |
| Nickel Limit (EU 2020/2081) | < 0.001% w/w |
| Benzo[a]pyrene (PAH) Limit | < 0.00005% w/w |
| Sum of 8 PAHs Limit | < 0.0005% w/w |
| Aromatic Amine Limit (azo) | < 0.001% w/w |
| Banned: Blue 15:3 (PB15:3) | EU Regulation 2020/2081 — banned Jan 2023 |
| Banned: Green 7 (PG7) | EU Regulation 2020/2081 — banned Jan 2023 |
| Pigment Load per cm² (typical) | ~2.5 mg dry weight |
| Carrier Glycerin Concentration | 1–10% typical |
References
- [1]EU Regulation (EU) 2020/2081 of 26 November 2020 restricting substances in tattoo inks. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32020R2081https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32020R2081
- [2]ISO/TR 17276:2015 — Nanomaterials: Analytical methods for tattoo inks. https://www.iso.org/standard/59604.htmlhttps://www.iso.org/standard/59604.html
- [3]ASTM D4303-10 — Standard Test Methods for Lightfastness of Colorants Used in Artists' Materials. https://www.astm.org/d4303-10.htmlhttps://www.astm.org/d4303-10.html
- [4]Lehner K. et al. (2011) "Black tattoo inks are a source of problematic substances such as dibutyl phthalate." Contact Dermatitis 65(4):231–238. https://doi.org/10.1111/j.1600-0536.2011.01939.xhttps://doi.org/10.1111/j.1600-0536.2011.01939.x
- [5]Wenzel S.M. et al. (2013) "Adverse reactions to permanent cosmetics." Dermatologic Surgery 39(4):516–525. https://doi.org/10.1111/dsu.12085https://doi.org/10.1111/dsu.12085
- [6]Serup J. et al. (2015) "Tattoo complaints and complications: diagnosis and clinical spectrum." Current Problems in Dermatology 48:48–60. https://doi.org/10.1159/000369225https://doi.org/10.1159/000369225
- [7]Brady B.G. et al. (2015) "Tattoo pigment." Clinics in Dermatology 33(6):638–643. https://doi.org/10.1016/j.clindermatol.2015.09.011https://doi.org/10.1016/j.clindermatol.2015.09.011
- [8]Schreiver I. et al. (2017) "Synchrotron-based ν-XRF mapping and μ-FTIR microscopy enable to look into the fate and effects of tattoo pigments in human skin." Scientific Reports 7:11395. https://doi.org/10.1038/s41598-017-11721-zhttps://doi.org/10.1038/s41598-017-11721-z
- [9]Laux P. et al. (2016) "A medical-toxicological view of tattooing." Lancet 387(10016):395–402. https://doi.org/10.1016/S0140-6736(15)60215-Xhttps://doi.org/10.1016/S0140-6736(15)60215-X
- [10]ECHA (European Chemicals Agency) — Restriction on tattoo inks and permanent make-up. https://echa.europa.eu/hot-topics/tattoo-inkshttps://echa.europa.eu/hot-topics/tattoo-inks
- [11]FDA — Tattoo Inks and the Risk of Infection (2019 guidance update). https://www.fda.gov/cosmetics/cosmetic-products/tattoos-permanent-makeuphttps://www.fda.gov/cosmetics/cosmetic-products/tattoos-permanent-makeup
- [12]BfR (German Federal Institute for Risk Assessment) — Health assessment of tattoo inks 2020. https://www.bfr.bund.de/en/press_information/2020/27/https://www.bfr.bund.de/en/press_information/2020/27/
Put Science Into Practice
This technical standard is the architectural foundation for our professional analytical tools.
